{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:49:00Z","timestamp":1774000140537,"version":"3.50.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in children, often leading to hospitalization in infants and vulnerable children. In low-resource settings where routine RSV diagnostics are unavailable, the overlap between clinical symptoms of RSV and those of bacterial pneumonia leads to unnecessary antibiotic use and contributes to the development of antimicrobial resistance. We conducted this study to evaluate the frequency and clinical determinants of antibiotic use among RSV-positive children under 2 years at a tertiary hospital in Ghana.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective observational sub-study nested within a longitudinal cohort of children at the Department of Child Health, Korle Bu Teaching Hospital, from June to November 2023. Eligible children aged &amp;lt;2\u202fyears with acute respiratory illness were enrolled and tested for RSV using molecular point-of-care testing. Antibiotic use and clinical characteristics were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 128 children enrolled, 72 (56.2%) tested positive for RSV. RSV-positive infants were significantly younger than RSV-negative infants (0\u20136\u202fmonths vs. &amp;gt;6\u202fmonths;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.02). Among children with confirmed RSV infection, 48 (66.7%) received a total of 78 antibiotic prescriptions, although only 11 (23%) had clinically suspected bacterial co-infections. The most frequently prescribed antibiotic class was penicillins (38\/78; 48.7%), followed by third-generation cephalosporins (17\/78; 21.8%). Antibiotic use was significantly associated with indicators of disease severity, including hypoxia (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.009), tachypnea (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.015), dyspnea (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), and hospital admission (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). Independent predictors of antibiotic use were difficulty in breathing (OR 33.0, 95% CI 4.2\u2013263.4;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.001) and tachypnea (OR 9.3, 95% CI 1.4\u201360.9;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Most RSV-positive children received antibiotics, often without confirmed bacterial co-infection. This highlights the need for antimicrobial stewardship, rapid diagnostics, and preventive strategies, such as maternal RSV vaccination, to reduce unnecessary antibiotic use and combat antimicrobial resistance in low-resource pediatric settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1696374","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:38:15Z","timestamp":1773988695000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic use in respiratory syncytial virus-positive children under two years: a prospective observational study at a tertiary hospital in Ghana"],"prefix":"10.3389","volume":"14","author":[{"given":"Joycelyn Assimeng","family":"Dame","sequence":"first","affiliation":[{"name":"Department of Child Health, University of Ghana Medical School, College of Health Sciences","place":["Accra, Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwabena Agyapong","family":"Osman","sequence":"additional","affiliation":[{"name":"Department of Child Health, University of Ghana Medical School, College of Health Sciences","place":["Accra, Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farina","family":"Shaaban","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University Medical Centre Utrecht","place":["Utrecht, Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangeline","family":"Obodai","sequence":"additional","affiliation":[{"name":"Virology Department, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana Legon","place":["Accra, Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clint","family":"Pecenka","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH","place":["Seattle, WA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Bont","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University Medical Centre Utrecht","place":["Utrecht, Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bamenla","family":"Goka","sequence":"additional","affiliation":[{"name":"Department of Child Health, University of Ghana Medical School, College of Health Sciences","place":["Accra, Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/QCO.0000000000000952","article-title":"The disease burden of respiratory syncytial virus in infants","volume":"36","author":"Munro","year":"2023","journal-title":"Curr Opin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ppul.23570","article-title":"Respiratory syncytial virus hospitalization and mortality: systematic review and meta-analysis","volume":"52","author":"Stein","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0140-6736(16)30951-5","article-title":"Viral bronchiolitis","volume":"389","author":"Florin","year":"2017","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e43393","DOI":"10.7759\/cureus.43393","article-title":"Evaluation of bronchiolitis in the pediatric population in the United States of America and Canada: a ten-year review","volume":"15","author":"Ajayi","year":"2023","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/ijerph16010027","article-title":"Drivers of irrational use of antibiotics in Europe","volume":"16","author":"Machowska","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e0203788","DOI":"10.1371\/journal.pone.0203788","article-title":"The significance of human respiratory syncytial virus (HRSV) in children from Ghana with acute lower respiratory tract infection: a molecular epidemiological analysis, 2006 and 2013-2014","volume":"13","author":"Obodai","year":"2018","journal-title":"PLoS One"},{"key":"ref8","year":"2018"},{"key":"ref9","volume-title":"Id now RSV","year":""},{"key":"ref10","volume-title":"AWaRe Classification of Antibiotics for Evaluation and Monitoring of Use","year":"2023"},{"key":"ref11","volume-title":"Castor Electronic Data Capture","year":"2019"},{"key":"ref12","volume-title":"Stata Statistical Software","year":"2023"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: a worldwide challenge","volume":"387","author":"Laxminarayan","year":"2016","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e1004235","DOI":"10.1371\/journal.pmed.1004235","article-title":"Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: a systematic review","volume":"20","author":"Luchen","year":"2023","journal-title":"PLoS Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jgar.2021.10.015","article-title":"Unnecessary antibiotic treatment of children hospitalized with respiratory syncytial virus (RSV) bronchiolitis: risk factors and prescription patterns","volume":"27","author":"Obolski","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2471\/BLT.22.288614","article-title":"The WHO AWaRe (access, watch, reserve) antibiotic book and prevention of antimicrobial resistance","volume":"101","author":"Zanichelli","year":"2023","journal-title":"Bull World Health Organ"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s40121-023-00815-z","article-title":"Rapid diagnostic test value and implementation in antimicrobial stewardship across low-to-middle and high-income countries: a mixed-methods review","volume":"12","author":"Moore","year":"2023","journal-title":"Infect Dis Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e633","DOI":"10.1016\/S2214-109X(16)30142-5","article-title":"Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomized controlled trial","volume":"4","author":"Do","year":"2016","journal-title":"Lancet Glob Health"},{"key":"ref19","year":"2025"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1696374\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:38:16Z","timestamp":1773988696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1696374\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":19,"alternative-id":["10.3389\/fpubh.2026.1696374"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1696374","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"article-number":"1696374"}}